8-K: BioCardia Sets 2025 Annual Meeting, Shareholder Deadlines

BioCardia, Inc. announced the date for its 2025 Annual Meeting of Stockholders and established new deadlines for shareholder proposals and director nominations.

Summary

• The 2025 Annual Meeting of Stockholders is scheduled for Tuesday, December 2, 2025, at 9:00 a.m. Pacific Time.
• The meeting will be held at Wilson Sonsini Goodrich & Rosati, P.C., 650 Page Mill Road, Palo Alto, California 94304-1050.
• The record date for stockholders entitled to vote at the Annual Meeting is the close of business on October 8, 2025.
• New deadlines have been set for shareholder proposals and director nominations because the Annual Meeting is held more than 30 days from the anniversary of the last annual meeting (May 20, 2024), in accordance with Rule 14a-5(f) under the Exchange Act.
• The deadline for shareholder proposals to be included in the Company's proxy statement is October 17, 2025.
• The deadline for stockholders to nominate a person for election to the Board or submit other business proposals (not for inclusion in proxy materials) is the close of business on October 17, 2025.
• Stockholders intending to solicit proxies for director nominees other than the Board's nominees must provide notice by October 17, 2025, as required by Rule 14a-19 (universal proxy rules).

Sentiment

Score: 5

Explanation: The filing is a standard procedural announcement regarding the annual meeting and shareholder nomination deadlines, carrying a neutral sentiment as it provides factual information without indicating positive or negative operational or financial performance.

Positives

• Clear communication of key dates and deadlines for shareholder participation in the annual meeting.
• Adherence to SEC regulations (Rule 14a-5(f), Rule 14a-8, Rule 14a-19) regarding annual meeting procedures and shareholder rights.

Future Outlook

The Company will electronically file its proxy statement for the Annual Meeting with the U.S. Securities and Exchange Commission prior to the Annual Meeting.

Management Comments

• The Board of Directors has established Tuesday, December 2, 2025, at 9:00 a.m. Pacific Time as the date and time for the 2025 Annual Meeting of Stockholders.
• The Board also established the close of business on October 8, 2025, as the record date for the determination of stockholders entitled to receive notice of and to vote at the Annual Meeting.

Industry Context

This announcement is a standard corporate governance disclosure, providing necessary information to shareholders regarding the upcoming annual meeting and their rights to participate. It does not directly relate to broader industry trends or competitive positioning but ensures compliance with regulatory requirements common across publicly traded companies.

Corporate Governance

Stakeholder Impact

• Shareholders: Provided with critical dates and deadlines for exercising their voting rights, submitting proposals, and nominating directors for the upcoming Annual Meeting.

Next Steps

• Electronic filing of the Company's proxy statement for the Annual Meeting with the SEC.
• Holding the 2025 Annual Meeting of Stockholders on December 2, 2025.

Key Dates

Keywords

BioCardia, BCDA, Annual Meeting, Shareholder Nomination, Proxy Statement, Corporate Governance, SEC Filing, 8-K